Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan vs Amlodipine on Endothelial Function in Hypertensive Metabolic Syndrome
NCT00241150Phase 4Completed
- Sponsor
- Novartis
- Start
- Nov 2002
- Primary completion
- Jan 2005
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of valsartan in hypertension (HTN) (2 arms), sponsored by Novartis. Primary endpoint: Change in baseline flow-mediated vasodilatation at 12 weeks. Started Nov 2002; status: completed.
02
Drugs
valsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00241150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00241150.